GRAIL (GRAL) to Commence Separate Trading on Nasdaq
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
GRAIL to Begin Trading on the Nasdaq Stock Exchange
June 24, 2024 4:05 PM EDTRegular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25
GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology
MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol GRAL as of tomorrow, June 25,... More



